O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of carmustine given together
with O(6)-benzylguanine in treating patients with stage I or stage II cutaneous T-cell
lymphoma that has not responded to previous treatment. Drugs used in chemotherapy use
different ways to stop cancer cells from dividing so they stop growing or die. Combining more
than one drug may kill more cancer cells